P

ProKidney Corp
NASDAQ:PROK

Watchlist Manager
ProKidney Corp
NASDAQ:PROK
Watchlist
Price: 2.23 USD -0.45% Market Closed
Market Cap: 670.9m USD

Relative Value

The Relative Value of one PROK stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.23 USD, ProKidney Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PROK Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
15
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8
Forward
820
vs History
vs Industry
Median 3Y
-9.4
Median 5Y
-9.5
Industry
23.5
Forward
-4.5
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-7.2
Industry
21.9
vs History
vs Industry
Median 3Y
-4.4
Median 5Y
-5.6
Industry
24.3
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
3.2
vs History
14
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.1
Forward
481.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
vs Industry
21
Median 3Y
-1
Median 5Y
-1.8
Industry
5.9
Forward
-2.5
vs History
vs Industry
20
Median 3Y
-1
Median 5Y
-1.7
Industry
6.2
Forward
-2.4
vs History
vs Industry
22
Median 3Y
-1.6
Median 5Y
-2.6
Industry
7.7
vs History
vs Industry
19
Median 3Y
-1.3
Median 5Y
-2.5
Industry
6.3
vs History
38
vs Industry
12
Median 3Y
3
Median 5Y
2.5
Industry
5.6

Multiples Across Competitors

PROK Competitors Multiples
ProKidney Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
ProKidney Corp
NASDAQ:PROK
658.4m USD 885 -9.3 -2.3 -2.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 837 682.7 -160 825.5 -195 293.4 -193 064.9
US
Abbvie Inc
NYSE:ABBV
405.3B USD 6.8 172.6 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
176.3B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
151B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.8B USD 9.8 31.2 22.9 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 082 -531.3 -578.5 -563.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.7B USD 5.7 17.9 17 19.3
AU
CSL Ltd
ASX:CSL
83.5B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.7B USD 16.4 1 210.6 163.2 198
NL
argenx SE
XBRU:ARGX
43.5B EUR 14.1 33.1 57.3 58.9
P/E Multiple
Earnings Growth PEG
US
P
ProKidney Corp
NASDAQ:PROK
Average P/E: 191
Negative Multiple: -9.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 825.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
172.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 210.6
N/A N/A
NL
argenx SE
XBRU:ARGX
33.1
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
P
ProKidney Corp
NASDAQ:PROK
Average EV/EBITDA: 40.1
Negative Multiple: -2.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 293.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.2
N/A N/A
NL
argenx SE
XBRU:ARGX
57.3
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
P
ProKidney Corp
NASDAQ:PROK
Average EV/EBIT: 46.3
Negative Multiple: -2.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 064.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.3
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198
N/A N/A
NL
argenx SE
XBRU:ARGX
58.9
N/A N/A